Oxford BioDynamics Agilent, Oxford BioDynamics Sign Supply, Resale Agreement for Array Kit Agilent will supply a custom-made SurePrint G3CGH Microarray for Oxford's newly launched Explorer Array Kit, which will include OBD's 3D Genome Probes. Scottish Researchers, Oxford BioDynamics Partner to Identify Epigenetic COVID-19 Biomarkers Premium The partners aim to identify signatures to predict the severity of disease in those infected and determine how patients will respond to therapies. Oxford BioDynamics Fiscal 2019 Revenues Down 24 Percent The UK-based company's revenues are generated exclusively from epigenetic biomarker research and development alliances with commercial and academic partners. Inex Innovate to Launch New Molecular Tests for Ovarian Cancer, Breast Cancer in Asia Premium The company's goal is to serve what it sees as a massive but underaddressed target group: Asian women. Singapore's Inex, Nova Satra Merge to Offer Dx Tests for Asian Women The new company, called Inex Innovate, aims by next year to introduce new tests for ovarian cancer and breast cancer in Asian women. Jun 14, 2019 People in the News: Thomas Schinecker, Amelia Warner, Bartu Ahiska, More Mar 19, 2019 Oxford Biodynamics Joins UK Prostate Cancer Screening Trial Dec 12, 2018 Oxford Biodynamics Posts Flat Revenues for FY 2018 Nov 12, 2018 Oxford BioDynamics Forms Autism Biomarker Alliance Oct 8, 2018 European PEP-NET Consortium Aims to Integrate Epigenetic Data With Mathematical Models Premium Aug 22, 2018 Oxford BioDynamics Inks Business Development Partnership for China; Gains $12.6M Investment Apr 11, 2018 Pfizer, Oxford BioDynamics, U of Glasgow Researchers Develop Approach to Gauge Response to RA Drug Premium Jan 29, 2018 Oxford BioDynamics, Holos to Develop Biomarkers for Sports-Related Concussions Oct 10, 2017 Oxford BioDynamics Advances Epigenetic Signatures for Breast Cancer, ALS Premium May 18, 2017 Oxford BioDynamics Licenses EpiSwitch to Nova Satra in Asia Breaking News Singular Genomics Systems Reports No Revenues, Increased Net Loss for Q2 Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib Gene Editing Analysis Firm SeQure Dx Closes $17.5M Series A Funding Round Resolve Biosciences, Zeiss Partner to Enhance Spatial Biology Imaging Tech EliTechGroup Obtains CE Mark for Saliva Use With SARS-CoV-2 Test Waters Q2 Revenues Up 31 Percent The Scan And Back The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database. Lacks Family Hires Attorney A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports. For the Unknown The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona. PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.